Formulation | Component drugs | Potential advantages | Potential disadvantages |
---|---|---|---|
Co-codamol | Paracetamol Codeine | Opioid/paracetamol synergy. | Opioid can cause confusion |
Co-amilofruse | Furosemide Amiloride | Potassium-sparing actions of amiloride. | Amiloride not always required, especially in those also taking ACE inhibitors. |
Co-fluampicil | Ampicillin Flucloxacillin | Broader antibacterial spectrum. | Wider spectrum rarely required. May encourage bacterial resistance if used inappropriately. |
Co-tenidone | Atenolol Chlorthalidone | Single tablet for the treatment of hypertension. | Two drugs are not always required. Not suitable for dose titration. |
Co-careldopa | Carbidopa L-dopa | Peripheral dopa decarboxylase inhibitor (carbidopa) reduces adverse effects from the peripheral conversion of L-dopa to dopamine. |
Advertisements